home
about
t-max™ platform
pipeline
team
partnerships
investors
contact
Press Releases
TerraProtein Equity Partners and MBF Therapeutics Inc. have entered into an Engagement Agreement
February 22, 2024
Australia, US Scientists Team Up on African Swine Fever Vaccine
November 8, 2023
Blog : Novel ASF Vaccine Research “Originally published at csiro.au”
November 8, 2023
MBF Therapeutics Inc. Announces the Appointment of Joseph Connor, DVM to the Board of Directors
February 16, 2023
MBF Therapeutics Announces Issuance of a U.S. Patent for Its T-Max™ DNA Vaccine Platform
January 12, 2022
MBF Therapeutics Announces Award of a National Science Foundation Grant to Use the T-Max™ DNA Vaccine Platform to Develop a Next-Generation SARS CoV-2 Vaccine
January 5, 2022
MBF Therapeutics Announces the Appointment of Two New Board Members
November 19, 2020
MBF Therapeutics Collaborates with Life Science Research Leaders to Develop a Next Generation Immunotherapeutic Vaccine for SARS CoV-2
July 23, 2020
MBF Therapeutics Teams Experts to Develop Effective, Broad-Spectrum Immunotherapeutic African Swine Fever Virus Vaccine
April 1, 2020
MBF Therapeutics Teams Experts to Develop Effective, Broad-Spectrum Immunotherapeutic African Swine Fever Virus Vaccine
January 10, 2020
MBF Therapeutics Names Ronald Cravens, MS, DVM, Executive Vice President of Business Development
January 7, 2020
MBF Therapeutics signs exclusive option agreement for UNC proprietary checkpoint inhibitors and vaccine delivery technology
July 30, 2019
MBF Therapeutics’ Founder and CEO Tom Tillett to speak at ASPIRE Philadelphia Dealmakers Conference
June 5, 2019
SwRI, MBF Therapeutics sign exclusive license for proprietary drug delivery system
May 9, 2019
Wistar Expands Collaboration & Signs Exclusive License Agreement with Man’s Best Friend Therapeutics to Develop Novel Veterinary Vaccine Technology
November 2, 2017
MBF Therapeutics Inc. to present at Philadelphia PACT Investor Conference
October 30, 2017
The Wistar Institute and Man’s Best Friend Therapeutics Announce Partnership to Advance Canine Melanoma Cancer Vaccine
November 17, 2016
